Advancements in NADH Oxidase Nanozymes: Bridging Nanotechnology and Biomedical Applications.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 39344219.
- Also identified by DOI 10.1002/adhm.202402785.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Nicotinamide adenine dinucleotide (NADH) oxidase (NOX) is key in converting NADH to NAD<sup>+</sup>, crucial for various biochemical pathways. However, natural NOXs are costly and unstable. NOX nanozymes offer a promising alternative with potential applications in bio-sensing, antibacterial treatments, anti-aging, and anticancer therapies. This review provides a comprehensive overview of the types, functional mechanisms, biomedical applications, and future research perspectives of NOX nanozymes. It also addresses the primary challenges and future directions in the research and development of NOX nanozymes, underscoring the critical need for continued investigation in this promising area. These challenges include optimizing the catalytic efficiency, ensuring biocompatibility, and achieving targeted delivery and controlled activity within biological systems. Additionally, the exploration of novel materials and hybrid structures holds great potential for enhancing the functional capabilities of NOX nanozymes. Future research directions can involve integrating advanced computational modeling with experimental techniques to better understand the underlying mechanisms and to design more effective nanozyme candidates. Collaborative efforts across disciplines such as nanotechnology, biochemistry, and medicine will be essential to unlock the full potential of NOX nanozymes in future biomedical applications.
Medical subject headings
- NADH, NADPH Oxidoreductases
- Nanotechnology
- Multienzyme Complexes
- Nanostructures